Peter Lichter
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Genomic variations and chromosomal abnormalities
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
Papers in
- Genetics 213
- Glioma Diagnosis and Treatment 122
- Chronic Lymphocytic Leukemia Research 90
- Genomic variations and chromosomal abnormalities 88
-
- Cancer Genomics and Diagnostics 42
- Co-authors
- Hartmut Doehner (96 shared papers)Stephan Stilgenbauer (87 shared papers)Axel Benner (47 shared papers)Martin Bentz (56 shared papers)Thomas John Cremer (19 shared papers)David C. Ward (13 shared papers)Stefan Joos (59 shared papers)Stefan M. Pfister (49 shared papers)
- Journals
- Blood (53 papers)International Journal of Cancer (34 papers)Genes Chromosomes and Cancer (30 papers)Acta Neuropathologica (25 papers)Genomics (22 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Peter Lichter
601 papers receiving 75.3k citations
Peter Lichter's Hit Papers
Peers
Comparison fields: 5 of 186
- Genetics 27.6k
- Cancer Research 9.7k
- Pathology and Forensic Medicine 4.9k
- Genetics 8.3k
- Molecular Biology 18k
Countries citing papers authored by Peter Lichter
This map shows the geographic impact of Peter Lichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lichter more than expected).
Fields of papers citing papers by Peter Lichter
This network shows the impact of papers produced by Peter Lichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lichter. The network helps show where Peter Lichter may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lichter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 609 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia Hit paper breakdown → | 2000 | 2710 |
| 2 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 3 | DNA methylation-based classification of central nervous system tumours Hit paper breakdown → | 2018 | 2219 |
| 4 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 5 | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Hit paper breakdown → | 2012 | 2087 |
| 6 | International network of cancer genome projects Hit paper breakdown → | 2010 | 1844 |
| 7 | Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Hit paper breakdown → | 2012 | 1522 |
| 8 | Molecular subgroups of medulloblastoma: the current consensus Hit paper breakdown → | 2011 | 1493 |
| 9 | The landscape of genomic alterations across childhood cancers Hit paper breakdown → | 2018 | 1176 |
| 10 | High-Resolution Mapping of Human Chromosome 11 by in Situ Hybridization with Cosmid Clones Hit paper breakdown → | 1990 | 1171 |
| 11 | Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Hit paper breakdown → | 2014 | 1069 |
| 12 | Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries Hit paper breakdown → | 1988 | 1001 |
| 13 | Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Hit paper breakdown → | 2015 | 915 |
| 14 | The whole-genome landscape of medulloblastoma subtypes Hit paper breakdown → | 2017 | 852 |
| 15 | K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas Hit paper breakdown → | 2012 | 816 |
| 16 | Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas Hit paper breakdown → | 2012 | 808 |
| 17 | A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling Hit paper breakdown → | 2006 | 788 |
| 18 | Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances Hit paper breakdown → | 1997 | 750 |
| 19 | New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Hit paper breakdown → | 2016 | 728 |
| 20 | Dissecting the genomic complexity underlying medulloblastoma Hit paper breakdown → | 2012 | 705 |
About Peter Lichter
Peter Lichter is a scholar working on Genetics, Cancer Research, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 609 papers that have together received 77.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (122 papers), Chronic Lymphocytic Leukemia Research (90 papers), Genomic variations and chromosomal abnormalities (88 papers), Cancer Genomics and Diagnostics (42 papers), Lymphoma Diagnosis and Treatment (42 papers), Genomics and Chromatin Dynamics (32 papers), Acute Myeloid Leukemia Research (23 papers) and Nuclear Structure and Function (17 papers). The work is most often cited by research in Genetics (27.6k citations), Cancer Research (9.7k citations), Pathology and Forensic Medicine (4.9k citations), Genetics (8.3k citations) and Molecular Biology (18k citations). Peter Lichter has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Hartmut Doehner, Stephan Stilgenbauer, Axel Benner, Martin Bentz, Thomas John Cremer, David C. Ward, Stefan Joos, Stefan M. Pfister, Lars Bullinger and Alexander Kröber. Their work appears in journals such as Blood, International Journal of Cancer, Genes Chromosomes and Cancer, Acta Neuropathologica and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.